Immunic (IMUX) Assets Average (2014 - 2026)
Immunic (IMUX) posted Assets Average of $106.9 million for Q1 2026, up 230.15% sequentially from $32.4 million in Q4 2025, and up 248.3% YoY from $30.7 million in Q1 2025.
Immunic (IMUX) Assets Average (2014 - 2026) Analysis & Trends
Immunic has reported Assets Average for 13 years, with the latest figure at $106.9 million in Q1 2026.
- Quarterly Assets Average rose 248.3% year-over-year to $106.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.9 million (up 248.3% YoY) and the FY2025 annual result came in at $32.5 million, down 31.78% from the prior year.
- Assets Average advanced to $106.9 million in Q1 2026 per IMUX's latest filing, from $32.4 million in the prior quarter.
- Over five years, Assets Average peaked at $144.5 million in Q1 2022 and troughed at $30.7 million in Q1 2025.
- A 5-year average of $86.1 million and a median of $79.2 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average plunged 61.26% in 2025, then jumped 248.3% in 2026.
- Over 5 years, Assets Average stood at $124.4 million in 2022, then tumbled by 51.26% to $60.6 million in 2023, then declined by 12.9% to $52.8 million in 2024, then sank by 38.7% to $32.4 million in 2025, then soared by 230.15% to $106.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $106.9 million, $32.4 million, and $51.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 174.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 174.46 Mn |
| Mar 31, 2026 | 106.90 Mn |
| Dec 31, 2025 | 32.38 Mn |
| Sep 30, 2025 | 51.07 Mn |
| Jun 30, 2025 | 40.97 Mn |
| Mar 31, 2025 | 30.69 Mn |
| Dec 31, 2024 | 52.82 Mn |
| Sep 30, 2024 | 75.63 Mn |
| Jun 30, 2024 | 95.32 Mn |
| Mar 31, 2024 | 79.23 Mn |
| Dec 31, 2023 | 60.64 Mn |
| Sep 30, 2023 | 77.86 Mn |
| Jun 30, 2023 | 98.81 Mn |
| Mar 31, 2023 | 118.31 Mn |
| Dec 31, 2022 | 124.42 Mn |
| Sep 30, 2022 | 129.87 Mn |
| Jun 30, 2022 | 144.29 Mn |
| Mar 31, 2022 | 144.51 Mn |
| Dec 31, 2021 | 147.93 Mn |
| Sep 30, 2021 | 146.41 Mn |